Endocannabinoids can open the pain gate

Science Signaling

Volumn 2, Issue 88, 2009, Pages

  Christie, MacDonald J ^a   Mallet, Christophe ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOCANNABINOID; CANNABINOID;

ANALGESIA; ANTINOCICEPTION; CHRONIC PAIN; GATE CONTROL THEORY; HUMAN; INFLAMMATION; NERVE INJURY; NONHUMAN; PRIORITY JOURNAL; SENSORY NERVE; SHORT SURVEY; SKIN; STIMULATION; ACUTE DISEASE; ANIMAL; ARTICLE; CHRONIC DISEASE; METABOLISM; NERVE CELL; PAIN; PATHOPHYSIOLOGY; PHYSIOLOGY; SPINAL CORD; SYNAPTIC TRANSMISSION;

ANIMALIA;

ACUTE DISEASE; ANIMALS; CANNABINOIDS; CHRONIC DISEASE; ENDOCANNABINOIDS; HUMANS; NEURONS; PAIN; SPINAL CORD; SYNAPTIC TRANSMISSION;

EID: 73949095515     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.288pe57     Document Type: Short Survey

References (34)

1. P. Pacher, S. Batkai, G. Kunos, The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev. 58, 389-462 (2006).
2. R. G. Pertwee, Cannabinoid receptors and pain. Prog. Neurobiol. 63, 569-611 (2001).
3. E. B. Russo, History of cannabis and its preparations in saga, science, and sobriquet. Chem. Biodivers. 4, 1614-1648 (2007).
4. B. Kraft, N. A. Frickey, R. M. Kaufmann, M. Reif, R. Frey, B. Gustorff, H. G. Kress, Lack of analgesia by oral standardized cannabis extract on acute inflammatory pain and hyperalgesia in volunteers. Anesthesiology 109, 101-110 (2008).
5. M. Naef, M. Curatolo, S. Petersen-Felix, L. Arendt- Nielsen, A. Zbinden, R. Brenneisen, The analgesic effect of oral delta-9-tetrahydrocannabinol (THC), morphine, and a THC-morphine combination in healthy subjects under experimental pain conditions. Pain 105, 79-88 (2003).
6. M.Wallace, G. Schulteis, J. H. Atkinson, T.Wolfson, D. Lazzaretto, H. Bentley, B. Gouaux, I. Abramson, Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers. Anesthesiology 107, 785-796 (2007).
7. M. Naef, S. Russmann, S. Petersen-Felix, R. Brenneisen, Development and pharmacokinetic characterization of pulmonal and intravenous delta-9- tetrahydrocannabinol (THC) in humans. J. Pharm. Sci. 93, 1176-1184 (2004).
8. 8.W. J. Redmond, P. Goffaux, S. Potvin, S. Marchand, Analgesic and antihyperalgesic effects of nabilone on experimental heat pain. Curr. Med. Res. Opin. 24, 1017-1024 (2008).
9. D. J. Buggy, L. Toogood, S. Maric, P. Sharpe, D. G. Lambert, D. J. Rowbotham, Lack of analgesic efficacy of oral delta-9-tetrahydrocannabinol in postoperative pain.Pain 106, 169-172 (2003).
10. F. A. Campbell, M. R. Tramer, D. Carroll, D. J. Reynolds, R. A. Moore, H. J. McQuay, Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. Br. Med. J. 323, 13-16 (2001).
11. M. Iskedjian, B. Bereza, A. Gordon, C. Piwko, T. R. Einarson, Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain. Curr. Med. Res. Opin. 23, 17-24 (2007).
12. 1 receptors mediate C-fiber-induced heterosynaptic pain plasticity. Science 325, 760-764 (2009).
13. G. Scherrer, N. Imamachi, Y. Q. Cao, C. Contet, F. Mennicken, D. O'Donnell, B. L. Kieffer, A. I. Basbaum, Dissociation of the opioid receptor mechanisms that control mechanical and heat pain. Cell 137, 1148-1159 (2009).
14. E. A. Jennings, C. W. Vaughan, M. J. Christie, Cannabinoid actions on rat superficial medullary dorsal horn neurons in vitro. J. Physiol. 534, 805-812 (2001).
15. Y. C. Liang, C. C. Huang, K. S. Hsu, T. Takahashi, Cannabinoid-induced presynaptic inhibition at the primary afferent trigeminal synapse of juvenile rat brainstem slices. J. Physiol. 555, 85-96 (2004).
16. V. Morisset, L. Urban, Cannabinoid-induced presynaptic inhibition of glutamatergic EPSCs in substantia gelatinosa neurons of the rat spinal cord. J. Neurophysiol. 86, 40-48 (2001).
17. N. Agarwal, P. Pacher, I. Tegeder, F. Amaya, C. E. Constantin, G. J. Brenner, T. Rubino, C.W. Michalski, G. Marsicano, K. Monory, K. Mackie, C. Marian, S. Batkai, D. Parolaro, M. J. Fischer, P. Reeh, G. Kunos, M. Kress, B. Lutz, C. J. Woolf, R. Kuner, Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nat. Neurosci. 10, 870-879 (2007).
18. J. Ahluwalia, L. Urban, S. Bevan, M. Capogna, I. Nagy, Cannabinoid 1 receptors are expressed by nerve growth factor- and glial cell-derived neurotrophic factor-responsive primary sensory neurones. Neuroscience 110, 747-753 (2002).
19. A. G. Hohmann, M. Herkenham, Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: A double-label in situ hybridization study. Neuroscience 90, 923-931 (1999).
20. C. A. Daniele, A. B. MacDermott, Low-threshold primary afferent drive onto GABAergic interneurons in the superficial dorsal horn of the mouse. J. Neurosci. 29, 686-695 (2009).
21. C. Torsney, A. B. MacDermott, Disinhibition opens the gate to pathological pain signaling in superficial neurokinin 1 receptor-expressing neurons in rat spinal cord. J. Neurosci. 26, 1833-1843 (2006).
22. J. A. Coull, S. Beggs, D. Boudreau, D. Boivin, M. Tsuda, K. Inoue, C. Gravel, M.W. Salter, Y. De Koninck, BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 438, 1017-1021 (2005).
23. J. A. Coull, D. Boudreau, K. Bachand, S. A. Prescott, F. Nault, A. Sik, P. De Koninck, Y. De Koninck, Transsynaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain. Nature 424, 938-942 (2003).
24. K. A. Moore, T. Kohno, L. A. Karchewski, J. Scholz, H. Baba, C. J.Woolf, Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord. J. Neurosci. 22, 6724-6731 (2002).
25. V. Chevaleyre, K. A. Takahashi, P. E. Castillo, Endocannabinoid- mediated synaptic plasticity in the CNS.Annu. Rev. Neurosci. 29, 37-76 (2006).
26. M. Kano, T. Ohno-Shosaku, Y. Hashimotodani, M. Uchigashima, M.Watanabe, Endocannabinoid-mediated control of synaptic transmission. Physiol. Rev. 89, 309-380 (2009).
27. H. U. Zeilhofer, B. Studler, D. Arabadzisz, C. Schweizer, S. Ahmadi, B. Layh, M. R. Bosl, J. M. Fritschy, Glycinergic neurons expressing enhanced green fluorescent protein in bacterial artificial chromosome transgenic mice. J. Comp. Neurol. 482, 123-141 (2005).
28. M. J. Caterina, M. A. Schumacher, M. Tominaga, T. A. Rosen, J. D. Levine, D. Julius, The capsaicin receptor: A heat-activated ion channel in the pain pathway. Nature 389, 816-824 (1997).
29. B. Fioravanti, M. De Felice, C. L. Stucky, K. A. Medler, M. C. Luo, L. R. Gardell, M. Ibrahim, T. P. Malan, Jr., H. I. Yamamura, M. H. Ossipov, T. King, J. Lai, F. Porreca, T.W.Vanderah, Constitutive activity at the cannabinoid CB1 receptor is required for behavioral response to noxious chemical stimulation of TRPV1: Antinociceptive actions of CB1 inverse agonists. J. Neurosci. 28, 11593-11602 (2008).
30. R. Nyilas, L. C. Gregg, K. Mackie, M.Watanabe, A. Zimmer, A. G. Hohmann, I. Katona, Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia. Eur. J. Neurosci. 29, 1964-1978 (2009).
31. G. M. Drew, P. J. Siddall, A.W. Duggan, Mechanical allodynia following contusion injury of the rat spinal cord is associated with loss of GABAergic inhibition in the dorsal horn.Pain 109, 379-388 (2004).
32. K. S. Vikman, A.W. Duggan, P. J. Siddall, Interferongamma induced disruption of GABAergic inhibition in the spinal dorsal horn in vivo. Pain 133, 18-28 (2007).
33. A. G. Hohmann, R. L. Suplita, N. M. Bolton, M. H. Neely, D. Fegley, R. Mangieri, J. F. Krey, J. M.Walker, P. V. Holmes, J. D. Crystal, A. Duranti, A. Tontini, M. Mor, G. Tarzia, D. Piomelli, An endocannabinoid mechanism for stress-induced analgesia. Nature 435, 1108-1112 (2005).
34. M.J.C. and C.M. are supported by National Health and Medical Research Council of Australia (NHMRC) program grant 351446. M.J.C. is also supported by NHMRC fellowship 511914.